A Review of the Impella Devices.
Publication/Presentation Date
1-1-2022
Abstract
The use of mechanical circulatory support (MCS) to provide acute haemodynamic support for cardiogenic shock or to support high-risk percutaneous coronary intervention (HRPCI) has grown over the past decade. There is currently no consensus on best practice regarding its use in these two distinct indications. Impella heart pumps (Abiomed) are intravascular microaxial blood pumps that provide temporary MCS during HRPCI or in the treatment of cardiogenic shock. The authors outline technical specifications of the individual Impella heart pumps and their accompanying technology, the Automated Impella Controller and SmartAssist, their indications for use and patient selection, implantation techniques, device weaning and escalation, closure strategies, anticoagulation regimens, complications, future directions and upcoming trials.
Volume
17
First Page
05
Last Page
05
ISSN
1756-1485
Published In/Presented At
Zein, R., Patel, C., Mercado-Alamo, A., Schreiber, T., & Kaki, A. (2022). A Review of the Impella Devices. Interventional cardiology (London, England), 17, e05. https://doi.org/10.15420/icr.2021.11
Disciplines
Medicine and Health Sciences
PubMedID
35474971
Department(s)
Department of Medicine
Document Type
Article